Member Info for Sagetrade

Super-Slinkey: Listen to the below from 5 minutes onwards and try telling me and the rest of the board again with a straight face that AN hasn't been prioritised as a sampling method for the Avacta LFT. Comical.

Your welcome.

https://www.***************************/avacta-group-agreement-with-astrea-bioseparations-the-perfect-deal-interview/412949846

Let's agree to disagree.

Proof will be in the pudding of course. Regardless of how the RNS reads, naïve IMO to think otherwise given what we know about the issues with saliva as a sampling method as well as HMG's CLEAR AND PUBLISHED preference for AN and the fact that was surely the reason they pivoted to it.......but you are of course entitled to your view.

Have a good day.

You really are like a spoilt little child aren't you? Embarrassing carry on.

Are you capable of having an informed debate or just resort to petty ad-hominem every time?

How have you corrected me?! You're talking absolute tosh IMO if you think AN hasn't been prioritised as a sampling method, but crack on.

You seriously don't think they have prioritised AN as a sampling method......? Regardless of the snippet you just posted, I think that's pretty naïve given the huge change in direction and snippets from gov tender and other docs that explicitly state "nasal (anterior nares and/or mid turbinate)" as priority 1 and saliva as priority 3 behind oral pharyngeal. I'm sure the spit test is still in development to some degree, but would seem disingenuous or misleading to suggest AN isn't the priority here IMO....

I'd suggest unlikely given our pivot and prioritisation of AN as a sampling method to be frank.

There are other spit tests out there, granted none that would appear close to the home use suggested in your post...

My guess would be some inaccuracies in the chinese whispers!

Totally agree, not cross ramping here at all and I'm not invested over there but the EBITDA multiple at current MCAP does look crazily under valued. As other says though, perhaps a business based on tech that is about to be overtaken....

One must not criticise Avacta
One must not criticise Avacta
One must not have any debate that isn’t in praise of Avacta.

This is not a discussion board it is a shrine to our one true leader Sir Al.

Praise be.

This would of been a very welcome update 5 months ago. What exactly have they been doing in the meantime?

To be apparently not close to a commercial, revenue generating product now is unforgivable, given where the BOD’s lead us to believe BAMS was in stage of development.

Anyone dressing this up as a good RNS in the context of previous comms and the fact we’ve apparently been in validation for months is IMO completely deluded.

Shambolic in my view.

Investors had been lead to believe BAMS was in validation at multiple sites and delays were due to access to samples within condor (AS said so himself at interims). Now looks like the assay was just being evaluated instead (for how long?!?!)

This to me is a worrying sign and shows a distinct lack of commercial acumen in bringing a product to market that we’ve now had to bring in the big boys to help save the day.

The comms is an absolute disgrace given where we thought BAMS was. Misleading and unclear, just not good enough.

Wyndrum - let’s be honest, if anyone is making investment decisions off the back of a Sujood post, then they probably shouldn’t be making investment decisions full stop!!!!

**** me, I thought your post on Monday was pointless.

Quick synopsis of my advice - investing ain't for you pal.

JDT - I agree.

As I stated in a previous post a day or two ago, I struggle to see how the BOD's comms can be so bad unless for very good reason. Let's hope we're right.

**THIS IS NOT A DERAMP** (Disclaimer in case little fanboy slinkey gets upset again - I'll only see a green box anyway).

I'm sure many would of noticed the news of ODX launching the Mologic ELISA test this morning.

Does pose the question of where our ELISA is and why manufacturing and distribution partners haven't been signed up yet given we thought it was ready to go 4 months ago? Is it being sold? We don't know...

I repeat, the IP, pipeline, future potential of Avacta far outweigh anything else in my PF, but there is some very pertinent questions for the BOD's to answer with regard to the status of all Covid related diagnostic products IMO.. No doubt we shall get answers soon!

I'd suggest the thread itself is actually very worthy of a mention given our ties with Abingdon and some of the recent discussions around a UK testing consortium etc.

Again, I simply don't understand the very childish comments aimed at anyone trying to have an informed debate. I wasn't being negative, deramping etc etc - was merely asking some questions, to which PL75 has provided one very sensible, logical response.

In any case, your posting history reads like a 10 year olds playground argument - take a look before commenting on the merits of other posters content.

Whilst I agree, surely what they state within the RNS does pour at least some scorn over some of the theories being suggested here over the last week or two. i.e. Govnt consortium with Avacta at the forefront, securing most of the capacity at ODX, BBI and Abingdon etc. Why would they procure for manufacture this overseas test, amongst others, and in doing so use up capacity, if bucket loads of govnt subsidised orders were about to come their way...

I don't know, still a LTH and believer here, but the "look at the silence from ODX, Abingdon etc" as well as Avacta argument in reference to testing solutions is no longer valid. I get the UK is only the tip of the iceberg in terms of the global market, but surely we need an update, or at least an indication, of where we sit ASAP, especially given the BOD's apparent strategy of focusing largely on the UK market to date....

https://www.londonstockexchange.com/news-article/ABDX/trading-update/14840047

“Contract manufacturing for partners” paragraph an interesting read. The specific tests mentioned wouldn’t appear to be Avacta.

ODX news today also, come on Al!!!

HL won't take mine either

Zoom, this is obviously the key question.

My view, FWIW, is that we are either on the cusp of gold and some huge announcements with HMG, OR, we have made very little to no progress since the aforementioned RNS..

I lean towards the former, given the recent soundbites from media, UK RTC etc, coupled with the fact I refuse to believe the BOD's comms can be this bad unless for very good reason.

Only time will tell.

https://aptamergroup.com/aptamer-group-and-cytiva-form-new-collaboration-for-the-development-of-covid-19-rapid-test/

Let's hope Cytiva do as poor a job for Aptamer as they did for us if it's a straight shoot out....(given need for capacity I'm not sure it is...)

Sujood, is this a parody account?

You must truly be the oracle if your sixth sense is guiding you to an AIM listed stocks share price in 8 months time.